196 related articles for article (PubMed ID: 35979677)
1. Efficacy of lasmiditan for the acute treatment of perimenstrual migraine.
MacGregor EA; Komori M; Krege JH; Baygani S; Vincent M; Pavlovic J; Igarashi H
Cephalalgia; 2022 Dec; 42(14):1467-1475. PubMed ID: 35979677
[TBL] [Abstract][Full Text] [Related]
2. Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine.
Doty EG; Krege JH; Jin L; Raskin J; Halker Singh RB; Kalidas K
Cephalalgia; 2019 Oct; 39(12):1569-1576. PubMed ID: 31266353
[TBL] [Abstract][Full Text] [Related]
3. Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
Ashina M; Vasudeva R; Jin L; Lombard L; Gray E; Doty EG; Yunes-Medina L; Kinchen KS; Tassorelli C
Headache; 2019 Nov; 59(10):1788-1801. PubMed ID: 31529622
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
Tepper SJ; Vasudeva R; Krege JH; Rathmann SS; Doty E; Vargas BB; Magis D; Komori M
Headache; 2020 Sep; 60(8):1601-1615. PubMed ID: 32634275
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study.
Ashina M; Reuter U; Smith T; Krikke-Workel J; Klise SR; Bragg S; Doty EG; Dowsett SA; Lin Q; Krege JH
Cephalalgia; 2021 Mar; 41(3):294-304. PubMed ID: 33541117
[TBL] [Abstract][Full Text] [Related]
6. Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Reuter U; Krege JH; Lombard L; Gomez Valderas E; Krikke-Workel J; Dell-Agnello G; Dowsett SA; Buse DC
Cephalalgia; 2022 Jan; 42(1):20-30. PubMed ID: 34644189
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patients.
Sakai F; Takeshima T; Homma G; Tanji Y; Katagiri H; Komori M
Headache; 2021 May; 61(5):755-765. PubMed ID: 33990951
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial.
Takeshima T; Komori M; Tanji Y; Ozeki A; Tatsuoka Y
Adv Ther; 2022 Nov; 39(11):5274-5288. PubMed ID: 36138260
[TBL] [Abstract][Full Text] [Related]
9. Safety Findings in Lasmiditan as a Novel Acute Treatment of Migraine in Chinese Patients: A Post Hoc Analysis of the Randomized Controlled Phase 3 CENTURION Trial.
Zhou J; Luo G; Xu Y; Yang X; Pan X; Dong Z; Zhong S; Liu H; Ji F; Yu S
Adv Ther; 2022 Nov; 39(11):5229-5243. PubMed ID: 36114949
[TBL] [Abstract][Full Text] [Related]
10. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.
Goadsby PJ; Wietecha LA; Dennehy EB; Kuca B; Case MG; Aurora SK; Gaul C
Brain; 2019 Jul; 142(7):1894-1904. PubMed ID: 31132795
[TBL] [Abstract][Full Text] [Related]
11. Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine.
Clemow DB; Hochstetler HM; Dong Y; Hauck P; Peres MFP; Ailani J
Postgrad Med; 2021 May; 133(4):449-459. PubMed ID: 33730977
[No Abstract] [Full Text] [Related]
12. Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.
Shapiro RE; Hochstetler HM; Dennehy EB; Khanna R; Doty EG; Berg PH; Starling AJ
J Headache Pain; 2019 Aug; 20(1):90. PubMed ID: 31464581
[TBL] [Abstract][Full Text] [Related]
13. The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials.
Doty EG; Hauck PM; Krege JH; Komori M; Hake AM; Dong Y; Lipton RB
CNS Drugs; 2022 Jul; 36(7):771-783. PubMed ID: 35779194
[TBL] [Abstract][Full Text] [Related]
14. A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN.
Lipton RB; Baygani SK; Tepper SJ; Krege JH; Vasudeva R; Pearlman EM; Hauck PM; Loo LS
J Headache Pain; 2021 Aug; 22(1):101. PubMed ID: 34454420
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.
Komori M; Ozeki A; Tanji Y; Kamiki E; Krege JH; Li LQ; Suzuki S; Shibata M; Takeshima T
J Headache Pain; 2024 Mar; 25(1):43. PubMed ID: 38528476
[TBL] [Abstract][Full Text] [Related]
16. The Effect and Safety of 5-HT
Gu P; Chen C; Wu Q; Dong C; Wang T; Wan Q; Dong X
Biomed Res Int; 2021; 2021():6663591. PubMed ID: 34660796
[TBL] [Abstract][Full Text] [Related]
17. Lasmiditan in patients with common migraine comorbidities: a
Clemow DB; Baygani SK; Hauck PM; Hultman CB
Curr Med Res Opin; 2020 Nov; 36(11):1791-1806. PubMed ID: 32783644
[TBL] [Abstract][Full Text] [Related]
18. Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial.
Matsumori Y; Komori M; Tanji Y; Ozeki A; Sakai F
Neurol Ther; 2022 Dec; 11(4):1721-1734. PubMed ID: 36136232
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.
Loo LS; Ailani J; Schim J; Baygani S; Hundemer HP; Port M; Krege JH
J Headache Pain; 2019 Jul; 20(1):84. PubMed ID: 31340760
[TBL] [Abstract][Full Text] [Related]
20. Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
Kuca B; Silberstein SD; Wietecha L; Berg PH; Dozier G; Lipton RB;
Neurology; 2018 Dec; 91(24):e2222-e2232. PubMed ID: 30446595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
